指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

脓毒症诊断试验开发面临的挑战:脓毒症联盟与感染管理及脓毒症协作社区的報告

Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community.
PubMed 文献 · Crit Care Explor · 2025-08-05
一句话结论专家共识指出,基于宿主的脓毒症诊断试验在监管审批中面临三大障碍:试验目标与输出的分类、脓毒症表现的异质性、以及缺乏通用定义。

本文为专家评审、结构化访谈和小型小组讨论形成的协作声明,由脓毒症联盟感染管理与脓毒症协作社区组织多国多学科专家完成。专家认为,当前针对基于宿主的脓毒症诊断试验的监管实践对监管方和产品开发者均构成重大挑战,最重要的审批障碍包括诊断试验目标与输出的分类、脓毒症表现和病程的异质性以及缺乏脓毒症的通用定义。潜在解决方案被非正式提出,但本阶段未进行严格探索。该协作声明旨在为利益相关方建立共同框架,以有效开展讨论并制定潜在解决方案。

要点

  • 专家共识认为,基于宿主的脓毒症诊断试验监管审批的三大最重要障碍是:诊断试验目标与输出的分类、脓毒症表现和病程的异质性、缺乏脓毒症的通用定义。
  • 该协作声明由脓毒症联盟感染管理与脓毒症协作社区组织,成员包括多国多学科脓毒症患者倡导组织、学术研究组、监管专家及私营公司临床负责人。
  • 潜在解决方案在本项目阶段被非正式提出,但未进行严格探索。
  • 本声明的目的是为利益相关方建立共同框架,以有效参与讨论并制定潜在解决方案。
  • 现有监管实践对监管方和产品开发者均构成重大挑战,影响基于宿主的脓毒症诊断工具的开发。

研究设计与关键结果

  • 研究类型为专家评审、结构化访谈和小型小组讨论,由脓毒症联盟感染管理与脓毒症协作社区组织,成员为多国多学科脓毒症患者倡导组织、学术研究组、监管专家及私营公司临床负责人。
  • 专家认为监管审批的最重要障碍为:诊断试验目标与输出的分类、脓毒症表现和病程的异质性、缺乏脓毒症的通用定义。
  • 潜在解决方案被非正式提出,但本阶段未进行严格探索。

证据类型、等级与局限

  • 证据类型:专家评审、结构化访谈和小型小组讨论形成的协作声明。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To characterize regulatory and clinical adoption challenges to developing host-based sepsis diagnostics and to establish a common framework for stakeholders to work together toward potential solutions to these challenges.

DESIGN: Expert review, structured interviews, and small group discussions with experienced clinicians and experts in diagnostic test development and regulatory issues.

SETTING: A series of large and small group conference calls conducted from January 2023 to September 2024, along with a review of the available evidence and scope of the issue.

SUBJECTS: A collaborative group of multinational and multidisciplinary sepsis-focused patient advocacy groups, academic research groups, regulatory experts, and executives and clinical leaders from private companies assembled by Sepsis Alliance's Infection Management and Sepsis Collaborative Community.

INTERVENTIONS: The implications of existing regulatory practices surrounding the evaluation of host-based sepsis diagnostics were examined using structured, small group interviews and discussions. The entire expert panel collated the findings of small groups, and consensus was achieved on the most salient points.

MEASUREMENTS AND MAIN RESULTS: For various reasons, current regulatory practices surrounding host-based sepsis diagnostics pose significant challenges to both regulators and product developers in creating optimal clinical tools. The most important barriers to regulatory approval were considered to be: classification of the diagnostic tests' goals and output, heterogeneity of sepsis presentation and course, and lack of universal definitions of sepsis. Potential solutions to the challenges were informally proposed, but were not explored rigorously at this project phase.

CONCLUSIONS: A collaborative statement was created outlining the challenges of developing diagnostic tests and devices for sepsis, including existing regulatory requirements surrounding host-based sepsis diagnostics and their implications for ultimate clinical deployment. Characterizing these challenges is a necessary first step to establish a common framework for stakeholders to effectively engage in discussions to develop potential solutions.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. McCurdy MT, Sweeney TE, Foster D, et al. Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community. Crit Care Explor. 2025. PMID: 40763176. doi:10.1097/CCE.0000000000001293

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。